OKYO Pharma Limited
General ticker "OKYO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $79.5M (TTM average)
OKYO Pharma Limited does not follow the US Stock Market performance with the rate: -15.6%.
Estimated limits based on current volatility of 2.3%: low 1.49$, high 1.56$
Factors to consider:
- Total employees count: 3 as of 2022
Short-term OKYO quotes
Long-term OKYO plot
Financial data
| YTD | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM |
| Operating Expenses | $7.19MM | $8.50MM |
| Operating Income | $-7.19MM | $-8.50MM |
| Non-Operating Income | $-0.78MM | $-0.44MM |
| Interest Expense | $0.88MM | $0.47MM |
| R&D Expense | $2.25MM | $1.81MM |
| Income(Loss) | $-7.97MM | $-8.94MM |
| Net Income(Loss)* | $-4.71MM | $-8.95MM |
| Stockholders Equity | $-5.55MM | $12.34MM |
| Assets | $3.68MM | $20.98MM |
| Operating Cash Flow | $-1.81MM | $-5.94MM |
| Capital expenditure | $0.00MM | $0.01MM |
| Investing Cash Flow | $-0.00MM | $-6.01MM |
| Financing Cash Flow | $2.66MM | $25.02MM |
| Earnings Per Share** | $-0.12 | $-0.24 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.